Liver Function's impact on drug processing revealed in new study
NCT ID NCT04546789
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 27 times
Summary
This study looked at how the drug evobrutinib is processed in people with different levels of liver impairment compared to those with healthy livers. Twenty-four participants received a single dose, and researchers measured drug levels in the blood and monitored safety. The goal was to understand if liver function changes how the drug works, which helps guide proper dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CRS Clinical Research Services Kiel GmbH
Kiel, Germany
Conditions
Explore the condition pages connected to this study.